Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1984 Jun 1;130(11):1449–1455.

The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.

D L Johnston, D E Manyari, W J Kostuk
PMCID: PMC1483318  PMID: 6145515

Abstract

The efficacy of two beta-receptor antagonists, propranolol and pindolol, was compared with that of a calcium antagonist, verapamil, in the treatment of exertional angina pectoris in 22 men (mean age 51 years). The clinical response and left ventricular function were evaluated with treadmill exercise and with radionuclide ventriculography performed while the patient was at rest or exercising supine with a bicycle ergometer. All the treatments significantly prolonged exercise duration (p less than 0.001) and reduced the number of patients terminating treadmill exercise because of angina (p less than 0.05). The resting heart rate was decreased markedly (p less than 0.001) by propranolol but only slightly (p less than 0.05) by pindolol and verapamil. The left ventricular ejection fraction during rest was unchanged by any treatment, but that during exercise was improved (p less than 0.05) by all the treatments. Patients who failed to gain relief from angina with one of the drugs often responded to another, and adverse reactions occurring with one drug did not necessarily occur with another. In summary, pindolol and verapamil were safe and effective alternatives to propranolol in the treatment of the exertional angina pectoris of these patients.

Full text

PDF
1449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aellig W. H. Clinical pharmacology of pindolol. Am Heart J. 1982 Aug;104(2 Pt 2):346–356. doi: 10.1016/0002-8703(82)90125-9. [DOI] [PubMed] [Google Scholar]
  2. Alderman E. L., Davies R. O., Crowley J. J., Lopes M. G., Brooker J. Z., Friedman J. P., Graham A. F., Matlof H. J., Harrison D. C. Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation. 1975 Jun;51(6):964–975. doi: 10.1161/01.cir.51.6.964. [DOI] [PubMed] [Google Scholar]
  3. Barrett A. M., Nunn B. Intrinsic sympathomimetic activity in relation to the precipitation of heart failure by beta-adrenoceptive blockade. Arch Int Pharmacodyn Ther. 1971 Jan;189(1):168–174. [PubMed] [Google Scholar]
  4. Battler A., Ross J., Jr, Slutsky R., Pfisterer M., Ashburn W., Froelicher V. Improvement of exercise-induced left ventricular dysfunction with oral propranolol in patients with coronary heart disease. Am J Cardiol. 1979 Aug;44(2):318–324. doi: 10.1016/0002-9149(79)90323-0. [DOI] [PubMed] [Google Scholar]
  5. Bonow R. O., Leon M. B., Rosing D. R., Kent K. M., Lipson L. C., Bacharach S. L., Green M. V., Epstein S. E. Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation. 1982 Jun;65(7):1337–1350. doi: 10.1161/01.cir.65.7.1337. [DOI] [PubMed] [Google Scholar]
  6. Campeau L. Letter: Grading of angina pectoris. Circulation. 1976 Sep;54(3):522–523. [PubMed] [Google Scholar]
  7. Coltart J., Alderman E. L., Robison S. C., Harrison D. C. Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man. Br Heart J. 1975 Apr;37(4):357–364. doi: 10.1136/hrt.37.4.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crawford M. H., Lindenfeld J., O'Rourke R. A. Effects of oral propranolol on left ventricular size and performance during exercise and acute pressure loading. Circulation. 1980 Mar;61(3):549–554. doi: 10.1161/01.cir.61.3.549. [DOI] [PubMed] [Google Scholar]
  9. Dehmer G. J., Falkoff M., Lewis S. E., Hillis L. D., Parkey R. W., Willerson J. T. Effect of oral propranolol on rest and exercise left ventricular ejection fraction, volumes, and segmental wall motion in patients with angina pectoris. Assessment with equilibrium gated blood pool imaging. Br Heart J. 1981 Jun;45(6):656–666. doi: 10.1136/hrt.45.6.656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frishman W., Kostis J., Strom J., Hossler M., Elkayam U., Goldner S., Silverman R., Davis R., Weinstein J., Sonnenblick E. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity. Am Heart J. 1979 Oct;98(4):526–535. doi: 10.1016/0002-8703(79)90261-8. [DOI] [PubMed] [Google Scholar]
  11. Frishman W., Silverman R., Strom J., Elkayam U., Sonnenblick E. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker. Am Heart J. 1979 Aug;98(2):256–262. doi: 10.1016/0002-8703(79)90229-1. [DOI] [PubMed] [Google Scholar]
  12. Hahn B., Strauer B. E. The influence of beta-adrenoceptor blockade on left ventricular function. Br J Clin Pharmacol. 1982;13(Suppl 2):305S–307S. doi: 10.1111/j.1365-2125.1982.tb01931.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hombach V., Braun V., Höpp H. W., Gil-Sanchez D., Behrenbeck D. W., Tauchert M., Hilger H. H. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise. Br J Clin Pharmacol. 1982;13(Suppl 2):285S–293S. doi: 10.1111/j.1365-2125.1982.tb01926.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kawai C., Konishi T., Matsuyama E., Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation. 1981 May;63(5):1035–1042. doi: 10.1161/01.cir.63.5.1035. [DOI] [PubMed] [Google Scholar]
  15. Klein H. O., Ninio R., Oren V., Lang R., Sareli P., DiSegni E., David D., Guerrero J., Kaplinsky E. The acute hemodynamic effects of intravenous verapamil in coronary artery disease. Assessment by equilibrium-gated radionuclide ventriculography. Circulation. 1983 Jan;67(1):101–110. doi: 10.1161/01.cir.67.1.101. [DOI] [PubMed] [Google Scholar]
  16. Kostis J. B., Frishman W., Hosler M. H., Thorsen N. L., Gonasun L., Weinstein J. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers. Am Heart J. 1982 Aug;104(2 Pt 2):496–504. doi: 10.1016/0002-8703(82)90146-6. [DOI] [PubMed] [Google Scholar]
  17. Manyari D. E., Kostuk W. J., Carruthers S. G., Johnston D. J., Purves P. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography. Am J Cardiol. 1983 Feb;51(3):427–433. doi: 10.1016/s0002-9149(83)80074-5. [DOI] [PubMed] [Google Scholar]
  18. Manyari D. E., Nolewajka A. J., Purves P., Donner A., Kostuk W. J. Comparative value of the cold-pressor test and supine bicycle exercise to detect subjects with coronary artery disease using radionuclide ventriculography. Circulation. 1982 Mar;65(3):571–579. doi: 10.1161/01.cir.65.3.571. [DOI] [PubMed] [Google Scholar]
  19. Phear D. N. Verapamil in angina: a double-blind trial. Br Med J. 1968 Jun 22;2(5607):740–741. doi: 10.1136/bmj.2.5607.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pine M. B., Citron P. D., Bailly D. J., Butman S., Plasencia G. O., Landa D. W., Wong R. K. Verapamil versus placebo in relieving stable angina pectoris. Circulation. 1982 Jan;65(1):17–22. doi: 10.1161/01.cir.65.1.17. [DOI] [PubMed] [Google Scholar]
  21. Robertson D., Kostuk W. J., Ahuja S. P. The localization of coronary artery stenoses by 12 lead ECG response to graded exercise test: support for intercoronary steal. Am Heart J. 1976 Apr;91(4):437–444. doi: 10.1016/s0002-8703(76)80324-9. [DOI] [PubMed] [Google Scholar]
  22. Rozanski A., Elkayam U., Berman D. S., Diamond G. A., Prause J., Swan H. J. Improvement of resting myocardial asynergy with cessation of upright bicycle exercise. Circulation. 1983 Mar;67(3):529–535. doi: 10.1161/01.cir.67.3.529. [DOI] [PubMed] [Google Scholar]
  23. Singh B. N., Roche A. H. Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J. 1977 Nov;94(5):593–599. doi: 10.1016/s0002-8703(77)80128-2. [DOI] [PubMed] [Google Scholar]
  24. Slutsky R., Watkins J., Costello D. Radionuclide evaluation of the systolic blood pressure/end-systolic volume relationship: response to pharmacologic agents in patients with coronary artery disease. Am Heart J. 1983 Jan;105(1):53–59. doi: 10.1016/0002-8703(83)90278-8. [DOI] [PubMed] [Google Scholar]
  25. Sorensen S. G., Ritchie J. L., Caldwell J. H., Hamilton G. W., Kennedy J. W. Serial exercise radionuclide angiography. Validation of count-derived changes in cardiac output and quantitation of maximal exercise ventricular volume change after nitroglycerin and propranolol in normal men. Circulation. 1980 Mar;61(3):600–609. doi: 10.1161/01.cir.61.3.600. [DOI] [PubMed] [Google Scholar]
  26. Subramanian B., Bowles M., Lahiri A., Davies A. B., Raftery E. B. Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. Am J Cardiol. 1981 Sep;48(3):529–535. doi: 10.1016/0002-9149(81)90084-9. [DOI] [PubMed] [Google Scholar]
  27. Tan A. T., Sadick N., Kelly D. T., Harris P. J., Freedman S. B., Bautovich G. Verapamil in stable effort angina: effects on left ventricular function evaluated with exercise radionuclide ventriculography. Am J Cardiol. 1982 Feb 1;49(2):425–430. doi: 10.1016/0002-9149(82)90520-3. [DOI] [PubMed] [Google Scholar]
  28. Taylor S. H., Silke B., Lee P. S. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? N Engl J Med. 1982 Mar 18;306(11):631–635. doi: 10.1056/NEJM198203183061102. [DOI] [PubMed] [Google Scholar]
  29. Weiner D. A., Klein M. D. Verapamil therapy for stable exertional angina pectoris. Am J Cardiol. 1982 Nov;50(5):1153–1157. doi: 10.1016/0002-9149(82)90436-2. [DOI] [PubMed] [Google Scholar]
  30. da Luz P. L., Monteiro de Barros L. F., Leite J. J., Pileggi F., Décourt L. V. Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion. Am J Cardiol. 1980 Feb;45(2):269–275. doi: 10.1016/0002-9149(80)90645-1. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES